Back to Authors

Wallick, Christopher J.

https://orcid.org/0000-0003-2521-5895

A5087507934 | I4210127237

Mayo Clinic

Avanir Pharmaceuticals (United States)

Citations 2

Total Migraine Freedom for Breath Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder (AVP-825) vs 100 mg Oral Sumatriptan from the COMPASS Study of Acute Treatment of Migraine (P6.098)

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.p6.098

Total Migraine Freedom for Breath Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder (AVP-825) vs 100 mg Oral Sumatriptan from the COMPASS Study of Acute Treatment of Migraine (I3.009)

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.i3.009